pNIPAm-Based pH and Thermoresponsive Copolymer Hydrogel for Hydrophobic and Hydrophilic Drug Delivery
Gels · 07.03.2024 · 10 (3) · 184
DOI: 10.3390/gels10030184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gels, online erschienen am 07.03.2024. Verfasst von Anandhu Mohan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nano Science and Technology Convergence, General Graduate School, Gachon University, 1342 Seongnam-Daero, Sujeong-gu, Seongnam-si 13120…. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
The regulated and targeted administration of hydrophobic and hydrophilic drugs is both promising and challenging in the field of drug delivery. Developing a hydrogel which is responsive to dual stimuli is considered a promising and exciting research area of study. In this work, melamine functionalized poly-N-isopropyl acrylamide-co-glycidyl methacrylate copolymer has been developed by copolymerizing glycidyl methacrylate (GMA) monomer with N-isopropyl acrylamide (NIPAm) and further functionalized with melamine units (pNIPAm-co-pGMA-Mela). The prepared pNIPAm-co-pGMA-Mela copolymer hydrogel was characterized using various characterization techniques, including 1H NMR, FTIR, SEM, zeta potential, and particle size analysis. A hydrophobic drug (ibuprofen, Ibu) and hydrophilic drug (5-fluorouracil, 5-Fu) were selected as model drugs. Dual pH and temperature stimuli-responsive drug release behavior of the pNIPAm-co-pGMA-Mela hydrogel was evaluated under different pH (pH 7.4 and 4.0) and temperature (25 °C, 37 °C, and 45 °C) conditions. Furthermore, the in vitro biocompatibility of the developed pNIPAm-co-pGMA-Mela copolymer hydrogel was determined on MDA-MB-231 cells. The pH and temperature-responsive drug delivery study results reveal that the pNIPAm-co-pGMA-Mela hydrogel system is responsive to both pH and temperature stimuli and exhibits about ~100% of Ibu and 5-Fu, respectively, released at pH 4.0/45 °C. Moreover, the MTT assay and hemocompatibility analysis results proved that the pNIPAm-co-pGMA-Mela hydrogel system is biocompatible and hemocompatible, suggesting that that it could be used for drug delivery applications. The experimental results suggest that the proposed pNIPAm-co-pGMA-Mela hydrogel system is responsive to dual pH and temperature stimuli, and could be a promising drug carrier system for both hydrophilic and hydrophobic drug delivery applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nano Science and Technology Convergence, General Graduate School, Gachon University, 1342 Seongnam-Daero, Sujeong-gu, Seongnam-si 13120, Gyeonggi-do, Republic of Korea.
- School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Gyeongbuk, Republic of Korea.
- Center for Advanced Chemistry, Institute of Research and Development, Duy Tan University, 03 Quang Trung, Hai Chau, Danang 550000, Vietnam.
- Faculty of Environmental and Chemical Engineering, Duy Tan University, 03 Quang Trung, Hai Chau, Danang 550000, Vietnam.
ORCID-Profile: Anandhu Mohan, Thi Tuong Vy Phan
Förderung
- National Research Foundation of Korea
Zitieren
APA
Mohan, A., Santhamoorthy, M., Phan, T. T. V., & Kim, S. C. (2024). pNIPAm-Based pH and Thermoresponsive Copolymer Hydrogel for Hydrophobic and Hydrophilic Drug Delivery. Gels, 10(3), 184. https://doi.org/10.3390/gels10030184
Vancouver
Mohan A, Santhamoorthy M, Phan TTV, Kim SC. pNIPAm-Based pH and Thermoresponsive Copolymer Hydrogel for Hydrophobic and Hydrophilic Drug Delivery. Gels. 2024;10(3):184. doi:10.3390/gels10030184
BibTeX
@article{Mohan2024,
author = {Mohan, Anandhu and Santhamoorthy, Madhappan and Phan, Thi Tuong Vy and Kim, Seong-Cheol},
title = {pNIPAm-Based pH and Thermoresponsive Copolymer Hydrogel for Hydrophobic and Hydrophilic Drug Delivery},
journal = {Gels},
year = {2024},
volume = {10},
number = {3},
pages = {184},
doi = {10.3390/gels10030184}
}
EUVIMED